1Daumerie C, Ludgate M, Costagliola S, et al. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy [J]. Eur J Endocrinol, 2002, 146 (1): 35-8.
4Anderson CK, Miller OF. Triad of exophthahnos, pretibial myxedema,and acropachy in a patient with Graves' disease. J Am Acad Dermatol, 2003,48:970-972.
5Fatourechi V. Pretibial myxedema pathophysiology and treatment options. Am J Clin Dermatol,2005 ,6 :295-309.
7Schwartz KM, Fatourechi V, Ahmed DD, et al. Dermopathy of Graves' disease (pretibial myxedema) :long-term outcome. J Clin Endocrinol Metab ,2002,87:438-446.
8Katarzyna WS, Katarzyna KV, Krystyna O. The metabolism of glycosaminoglycans in the course of Graves' disease. Postepy Hig Med Dosw ,2006,60 : 184-191.
9Daumerie C,Ludgate M. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol,2002 ,146 :35-38.
10Cho S, Chol JH,Sung KJ,et al. Graves' disease presenting as elephantiasic pretibial myxedema and nodules of the hands. Int J Dermatol,2001,40 :276-277.
